KIMBERLY PORTER: Open Payments
NPI 1588370563 · CENTER CONWAY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 54 payments from 10 companies in 2025. Trend: 2023 $535 · 2024 $529 · 2025 $1,046
Food & beverage: $1,046
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $188 |
| Alkermes, Inc. | 9 | $168 |
| ABBVIE INC. | 8 | $136 |
| Janssen Pharmaceuticals, Inc | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $74 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Lundbeck LLC | 3 | $50 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: CAPLYTA, COBENFY, ARISTADA, VRAYLAR, REXULTI, INVEGA SUSTENNA, Auvelity, INGREZZA.
Industry payments across NH — which companies pay providers there.
